These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

276 related articles for article (PubMed ID: 9015703)

  • 1. Different coexisting endometrial histological features in asymptomatic postmenopausal breast cancer patients treated with tamoxifen.
    Cohen I; Altaras MM; Shapira J; Tepper R; Cordoba M; Figer A; Zalel Y; Dror Y; Beyth Y
    Gynecol Obstet Invest; 1997; 43(1):60-3. PubMed ID: 9015703
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Endometrial histologic changes in post-menopausal breast cancer patients using tamoxifen.
    Marchesoni D; Driul L; Fabiani G; Di Loreto C; Cataldi P; Mozzanega B
    Int J Gynaecol Obstet; 2001 Dec; 75(3):257-62. PubMed ID: 11728486
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Postmenopausal endometrial pathologies with tamoxifen treatment: comparison between hysteroscopic and hysterectomy findings.
    Cohen I; Azaria R; Aviram R; Bernheim J; Tepper R; Cordoba M; Beyth Y
    Gynecol Obstet Invest; 1999; 48(3):187-92. PubMed ID: 10545744
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Time-dependent effect of tamoxifen therapy on endometrial pathology in asymptomatic postmenopausal breast cancer patients.
    Cohen I; Altaras MM; Shapira J; Tepper R; Rosen DJ; Cordoba M; Zalel Y; Figer A; Yigael D; Beyth Y
    Int J Gynecol Pathol; 1996 Apr; 15(2):152-7. PubMed ID: 8786205
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Indication for histological examination of endometrium in breast carcinoma patients receiving tamoxifen therapy.
    Ito T; Katagiri C; Murata Y; Hamazoe R; Morita K
    J Obstet Gynaecol Res; 2001 Jun; 27(3):141-5. PubMed ID: 11561830
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Value of the progesterone test in screening for endometrial pathology in asymptomatic postmenopausal women receiving treatment with tamoxifen.
    Lubian López DM; Fernandez YG; Rodríguez BR; López FM; Delgado RC
    Menopause; 2010; 17(3):487-93. PubMed ID: 20464783
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tamoxifen use and endometrial lesions: hysteroscopic, histological, and immunohistochemical findings in postmenopausal women with breast cancer.
    Dibi RP; Zettler CG; Pessini SA; Ayub AV; de Almeida SB; da Silveira GP
    Menopause; 2009; 16(2):293-300. PubMed ID: 19034048
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A simple inexpensive screening test for endometrial abnormalities in asymptomatic women using tamoxifen.
    Archer DF
    Menopause; 2010; 17(3):454-5. PubMed ID: 20386342
    [No Abstract]   [Full Text] [Related]  

  • 9. Risk Factors Associated with Endometrial Pathology in Premenopausal Breast Cancer Patients Treated with Tamoxifen.
    Lee M; Piao J; Jeon MJ
    Yonsei Med J; 2020 Apr; 61(4):317-322. PubMed ID: 32233174
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevalence of endometrial proliferation in pipelle biopsies in tamoxifen-treated postmenopausal women with breast cancer in Kuwait.
    Al-Azemi M; Labib NS; Motawy MM; Temmim L; Moussa MA; Omu AE
    Med Princ Pract; 2004; 13(1):30-4. PubMed ID: 14657616
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Indication of hysteroscopy in tamoxifen treated breast cancer patients.
    Taponeco F; Curcio C; Fasciani A; Giuntini A; Artini PG; Fornaciari G; Petraglia F; Genazzani AR
    J Exp Clin Cancer Res; 2002 Mar; 21(1):37-43. PubMed ID: 12071527
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Discrepancy between ultrasonography and hysteroscopy and histology of endometrium in postmenopausal breast cancer patients using tamoxifen.
    Mourits MJ; Van der Zee AG; Willemse PH; Ten Hoor KA; Hollema H; De Vries EG
    Gynecol Oncol; 1999 Apr; 73(1):21-6. PubMed ID: 10094875
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparative study of transvaginal ultrasonographic and diagnostic hysteroscopic findings in postmenopausal breast cancer patients treated with tamoxifen.
    Gao WL; Zhang LP; Feng LM
    Chin Med J (Engl); 2011 Aug; 124(15):2335-9. PubMed ID: 21933565
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Endometrial evaluation in postmenopausal breast cancer patients receiving tamoxifen: an ultrasound, color flow Doppler, hysteroscopic and histological study.
    Exacoustos C; Zupi E; Cangi B; Chiaretti M; Arduini D; Romanini C
    Ultrasound Obstet Gynecol; 1995 Dec; 6(6):435-42. PubMed ID: 8903921
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Limited value of sonohysterography for endometrial screening in asymptomatic, postmenopausal patients treated with tamoxifen.
    Cohen I
    Gynecol Oncol; 2001 Aug; 82(2):406-7. PubMed ID: 11531305
    [No Abstract]   [Full Text] [Related]  

  • 16. The role of endovaginal ultrasonography and the value of endometrial biopsy in breast cancer patients on tamoxifen therapy.
    Sivalingam N; Pathmalingam A
    Singapore Med J; 1999 Jun; 40(6):402-4. PubMed ID: 10489508
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Tamoxifen and endometrial pathology].
    Negoiţă M; Terinte C; Mihailovici MS
    Rev Med Chir Soc Med Nat Iasi; 2010; 114(4):1114-7. PubMed ID: 21500468
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Changes mimicking endometrial neoplasia in postmenopausal, tamoxifen-treated women with breast cancer: a transvaginal Doppler study.
    Achiron R; Lipitz S; Sivan E; Goldenberg M; Horovitz A; Frenkel Y; Mashiach S
    Ultrasound Obstet Gynecol; 1995 Aug; 6(2):116-20. PubMed ID: 8535913
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Limited value of sonohysterography for endometrial screening in asymptomatic, postmenopausal patients treated with tamoxifen.
    Bertelli G; Valenzano M; Costantini S; Rissone R; Angiolini C; Signorini A; Gustavino C
    Gynecol Oncol; 2000 Sep; 78(3 Pt 1):275-7. PubMed ID: 10985880
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Abnormalities detected on transvaginal ultrasonography in tamoxifen-treated postmenopausal breast cancer patients may represent endometrial cystic atrophy.
    McGonigle KF; Shaw SL; Vasilev SA; Odom-Maryon T; Roy S; Simpson JF
    Am J Obstet Gynecol; 1998 Jun; 178(6):1145-50. PubMed ID: 9662294
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.